| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 20% | +37% | $18,349,040 | +$12,832,820 | 11,914,961 | +233% | BEHZAD AGHAZADEH | 28 Feb 2025 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 10% | $7,280,365 | 4,727,510 | SUVRETTA CAPITAL MANAGEMENT, LLC | 04 Mar 2025 | |||
| ORBIMED ADVISORS LLC | 8.9% | $6,415,640 | 4,166,000 | OrbiMed Advisors LLC | 31 Mar 2025 | |||
| ABG Management Ltd. | 6.3% | $4,488,492 | 2,914,605 | Fan Yu | 04 Mar 2025 | |||
| Coastlands Capital LP | 6% | $5,074,587 | 2,819,215 | Coastlands Capital LP | 19 Aug 2025 | |||
| BML Investment Partners, L.P. | 5% | -49% | $3,749,900 | -$331,178 | 2,435,000 | 0% | Leonard Braden Michael | 05 Mar 2025 |
| QVT Financial LP | 9.4% | $3,563,101 | 2,313,702 | QVT Financial LP | 31 Dec 2024 | |||
| Desai Neil | 4.9% | -48% | $3,500,329 | +$14,438 | 2,272,941 | +0.41% | Neil Desai | 04 Mar 2025 |
| ACUTA CAPITAL PARTNERS, LLC | 7.8% | $2,958,797 | 1,921,297 | Anupam Dalal | 19 Dec 2024 | |||
| EcoR1 Capital, LLC | 1.4% | $531,690 | 345,253 | EcoR1 Capital, LLC | 31 Dec 2024 | |||
| Point72 Asset Management, L.P. | 0% | -100% | $7,834 | -$2,256,445 | 5,087 | -100% | Point72 Asset Management, L.P. | 31 Mar 2025 |
| Satter Muneer A | 0% | $1,015 | 659 | Satter Muneer A | 31 Dec 2024 |
As of 31 Dec 2025, 47 institutional investors reported holding 32,977,477 shares of Whitehawk Therapeutics, Inc. - Common stock (WHWK). This represents 70% of the company’s total 47,144,064 outstanding shares.
The largest institutional shareholders of Whitehawk Therapeutics, Inc. - Common stock (WHWK) together control 69% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| QVT Financial LP | 9.8% | 4,615,709 | 0% | 1% | $10,611,515 |
| ORBIMED ADVISORS LLC | 8.8% | 4,166,000 | 0% | 0.22% | $10,081,720 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7.8% | 3,700,000 | 0% | 0.22% | $8,954,000 |
| ACUTA CAPITAL PARTNERS, LLC | 7.2% | 3,410,402 | 0% | 5.6% | $8,253,173 |
| Avoro Capital Advisors LLC | 6% | 2,849,402 | 0% | 0.07% | $6,895,553 |
| KVP Capital Advisors, LP | 4.6% | 2,165,997 | 0% | 5.4% | $5,241,714 |
| Siren, L.L.C. | 4.4% | 2,082,000 | 0% | 0.15% | $5,038,440 |
| Yu Fan | 4.4% | 2,070,000 | 0% | 5.4% | $5,009,400 |
| VANGUARD GROUP INC | 3.4% | 1,590,117 | +18% | 0% | $3,848,082 |
| STEMPOINT CAPITAL LP | 3.1% | 1,458,807 | +244% | 0.61% | $3,530,313 |
| ACORN CAPITAL ADVISORS, LLC | 2.4% | 1,139,363 | 0% | 0.93% | $2,757,258 |
| Ally Bridge Group (NY) LLC | 1.7% | 817,939 | 0% | 3.1% | $1,979,412 |
| RENAISSANCE TECHNOLOGIES LLC | 0.93% | 440,722 | -3.7% | 0% | $1,066,547 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.9% | 425,440 | +11% | 0% | $1,030,005 |
| TWO SIGMA INVESTMENTS, LP | 0.66% | 309,865 | 0% | $749,873 | |
| BlackRock, Inc. | 0.63% | 299,011 | +0.96% | 0% | $723,607 |
| Eversept Partners, LP | 0.55% | 260,259 | 0.04% | $629,827 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.46% | 215,284 | 0% | 0.01% | $520,987 |
| STATE STREET CORP | 0.31% | 145,537 | +112% | 0% | $352,200 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.23% | 110,083 | 0% | $266,401 | |
| NORTHERN TRUST CORP | 0.22% | 103,452 | +43% | 0% | $250,354 |
| CITADEL ADVISORS LLC | 0.21% | 98,950 | -29% | 0% | $239,459 |
| ADAR1 Capital Management, LLC | 0.16% | 77,593 | 0.01% | $187,775 | |
| Qube Research & Technologies Ltd | 0.15% | 72,348 | 0% | $175,082 | |
| JANE STREET GROUP, LLC | 0.15% | 69,931 | +177% | 0% | $169,233 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 32,977,477 | $79,245,821 | +$5,008,841 | $2.42 | 47 |
| 2025 Q3 | 28,831,370 | $54,340,996 | -$1,110,993 | $1.90 | 39 |
| 2025 Q2 | 29,433,136 | $54,608,497 | -$4,256,988 | $1.87 | 38 |
| 2025 Q1 | 31,810,129 | $56,220,211 | +$29,068,777 | $1.78 | 48 |
| 2024 Q4 | 14,964,504 | $47,212,864 | +$5,023,549 | $3.16 | 51 |
| 2024 Q3 | 11,974,976 | $24,667,146 | +$1,827,419 | $2.06 | 51 |
| 2024 Q2 | 11,470,837 | $16,746,144 | -$3,322,352 | $1.46 | 63 |
| 2024 Q1 | 13,209,848 | $30,910,957 | +$1,200,705 | $2.34 | 59 |
| 2023 Q4 | 12,774,914 | $25,805,815 | -$10,140,228 | $2.02 | 62 |
| 2023 Q3 | 14,216,215 | $68,812,109 | +$1,540,803 | $4.84 | 69 |
| 2023 Q2 | 13,790,216 | $94,355,740 | -$714,623 | $6.84 | 65 |
| 2023 Q1 | 13,831,279 | $100,129,503 | -$16,765,639 | $7.24 | 68 |
| 2022 Q4 | 15,301,334 | $192,201,785 | +$3,741,246 | $12.83 | 73 |
| 2022 Q3 | 14,991,886 | $211,814,933 | +$32,802,356 | $14.13 | 65 |
| 2022 Q2 | 12,823,915 | $158,008,315 | +$4,841,924 | $12.32 | 65 |
| 2022 Q1 | 12,574,186 | $213,400,829 | -$7,136,755 | $16.97 | 51 |
| 2021 Q4 | 12,184,052 | $294,238,682 | +$23,944,526 | $24.15 | 44 |
| 2021 Q3 | 11,096,563 | $324,110,000 | +$324,110,000 | $29.37 | 30 |